U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 215110

MAVYRET (GLECAPREVIR; PIBRENTASVIR)
50MG;20MG/PACKET
Marketing Status: Prescription
Active Ingredient: GLECAPREVIR; PIBRENTASVIR
Proprietary Name: MAVYRET
Dosage Form; Route of Administration: PELLETS; ORAL
Strength: 50MG;20MG/PACKET
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N215110
Product Number: 001
Approval Date: Jun 10, 2021
Applicant Holder Full Name: ABBVIE INC
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top